Cargando…

Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson’s Disease Assessed by the Unified Parkinson’s Disease Rating Scale and the Hoehn–Yahr Stage

Many genetic variants have been linked to familial or sporadic Parkinson’s disease (PD), among which those identified in PARK16, BST1, SNCA, LRRK2, GBA and MAPT genes have been demonstrated to be the most common risk factors worldwide. Moreover, complex gene-gene and gene-environment interactions ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Chen, Zheng, Zheng, Wang, Qi, Wang, Chaodong, Zhang, Dabao, Zhang, Min, Chan, Piu, Wang, Xiaomin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907455/ https://www.ncbi.nlm.nih.gov/pubmed/27299523 http://dx.doi.org/10.1371/journal.pone.0155758

Ejemplares similares

Changes in Cortical Thickness in Patients With Early Parkinson’s Disease at Different Hoehn and Yahr Stages
por: Gao, Yuyuan, et al.
Publicado: (2018)

Total Cerebral Small Vessel Score Association With Hoehn and Yahr Stage in Parkinson’s Disease
por: Ma, Xinxin, et al.
Publicado: (2021)

Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson’s Disease Motor Progression
por: Jackson, Holly, et al.
Publicado: (2021)

Time Taken for and Causes of a Decline to Hoehn and Yahr Stage 5 in Patients with Parkinson's Disease
por: Kashihara, Kenichi, et al.
Publicado: (2022)

Association between Fatigue and Hoehn-Yahr Staging in Parkinson’s Disease: Eight-Year Follow-Up Study
por: Kataoka, Hiroshi, et al.
Publicado: (2021)

Differences in Home Health Nursing Care for Patients with Parkinson's Disease by Stage of Progress: Patients in Hoehn and Yahr Stages III, IV, and V
por: Iwasa, Yumi, et al.
Publicado: (2021)

Efficacy of Rotigotine at Different Stages of Parkinson’s Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage
por: Giladi, Nir, et al.
Publicado: (2016)

Association between Hoehn and Yahr, Mini-Mental State Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I 123 injection (DaTSCAN™) in subjects with clinically uncertain parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2014)

Confirmatory Factor Analysis of the Motor Unified Parkinson's Disease Rating Scale
por: Vassar, Stefanie D., et al.
Publicado: (2012)

Graph Theoretical Analysis of Semantic Fluency in Patients with Parkinson's Disease
por: Zhang, Guanyu, et al.
Publicado: (2022)

Visualization of the Movement Disorder Society Unified Parkinson’s Disease Rating Scale Results
por: Hixson, Jaimie, et al.
Publicado: (2023)

Relationship between manual dexterity and the unified parkinson’s disease rating scale-motor exam
por: Hwang, Sujin, et al.
Publicado: (2016)

Ensemble deep model for continuous estimation of Unified Parkinson’s Disease Rating Scale III
por: Hssayeni, Murtadha D., et al.
Publicado: (2021)

Tracking Response Dynamics of Sequential Working Memory in Patients With Mild Parkinson’s Disease
por: Zhang, Guanyu, et al.
Publicado: (2021)

Impaired serial ordering in nondemented patients with mild Parkinson’s disease
por: Ma, Jinghong, et al.
Publicado: (2018)

Alterations of Erythrocytic Phosphorylated Alpha-Synuclein in Different Subtypes and Stages of Parkinson's Disease
por: Li, Xu-Ying, et al.
Publicado: (2021)

Applications of Machine Learning to Diagnosis of Parkinson’s Disease
por: Lai, Hong, et al.
Publicado: (2023)

Effects of different levodopa doses on blood pressure in older patients with early and middle stages of Parkinson's disease
por: Su, Dan, et al.
Publicado: (2023)

Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real‐world Unified Parkinson's Disease Rating Scale
por: Chae, Dongwoo, et al.
Publicado: (2021)

Subcortical grey matter changes associated with motor symptoms evaluated by the Unified Parkinson’s disease Rating Scale (part III): A longitudinal study in Parkinson’s disease
por: Charroud, Céline, et al.
Publicado: (2021)

The cerebellum in dual-task performance in Parkinson’s disease
por: Gao, Linlin, et al.
Publicado: (2017)

Retinal Structure Abnormalities in Parkinson’s Disease and Atypical Parkinsonism
por: Ma, Xinxin, et al.
Publicado: (2023)

Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
por: Xu, Shengli, et al.
Publicado: (2015)

Validation Study of the Official Korean Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale
por: Park, Jinse, et al.
Publicado: (2020)

Validation of the Thai Version of the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale
por: Jagota, Priya, et al.
Publicado: (2022)

Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia
por: Pahwa, Rajesh, et al.
Publicado: (2022)

Gait video-based prediction of unified Parkinson’s disease rating scale score: a retrospective study
por: Eguchi, Katsuki, et al.
Publicado: (2023)

Health-Related Quality of Life in Parkinson disease: Correlation between Health Utilities Index III and Unified Parkinson's Disease Rating Scale (UPDRS) in U.S. male veterans
por: Kleiner-Fisman, Galit, et al.
Publicado: (2010)

Musculoskeletal Pain in Parkinson's Disease
por: Li, Jun, et al.
Publicado: (2022)

Editorial: Neuroimaging in Parkinson's disease and Parkinsonism
por: Zhang, Yu, et al.
Publicado: (2023)

The recommendations of Chinese Parkinson’s disease and movement disorder society consensus on therapeutic management of Parkinson’s disease
por: Chen, Shengdi, et al.
Publicado: (2016)

The psychometric properties of the Chinese version of the Parkinson Anxiety Scale (C-PAS) among Parkinson’s disease
por: Jiang, Yuanyuan, et al.
Publicado: (2023)

Erratum: Validation Study of the Official Korean Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale
por: Park, Jinse, et al.
Publicado: (2021)

Multimodal Data for the Detection of Freezing of Gait in Parkinson’s Disease
por: Zhang, Wei, et al.
Publicado: (2022)

Editorial: Integrative Approach to Parkinson's Disease
por: Kim, Seung-Nam, et al.
Publicado: (2019)

Validation of the Parkinson Fatigue Scale in Chinese Parkinson's disease patients
por: Fu, Rao, et al.
Publicado: (2017)

Validation study of the Parkinson’s Fatigue Scale in advanced Parkinson’s disease
por: Martinez-Martin, Pablo, et al.
Publicado: (2019)

KTN1 Variants Underlying Putamen Gray Matter Volumes and Parkinson’s Disease
por: Mao, Qiao, et al.
Publicado: (2020)

Impaired Formation and Expression of Goal-Directed and Habitual Control in Parkinson’s Disease
por: Mi, Tao-Mian, et al.
Publicado: (2021)

An Exploration of Apathy and Impulsivity in Parkinson Disease
por: Ahearn, David J., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_31945jpdkuip8jq9a3bas58sdb